Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia
- PMID: 20492336
- DOI: 10.1111/j.1440-1746.2009.06168.x
Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia
Abstract
Background and aims: To examine the rate of Helicobacter pylori infection and the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in gastric mucosa with intestinal metaplasia or dysplasia, and explore their correlations in precancerous gastric lesions.
Methods: A total of 172 patients were included in the study. H. pylori infection was evaluated by hematoxylin-eosin and modified Giemsa staining. The expression of COX-2 and VEGF proteins was detected by immunohistochemistry.
Results: The rates of H. pylori infection in gastric mucosal dysplasia (DYS), intestinal metaplasia in gastric mucosa (IM), chronic atrophic gastritis (CAG) and chronic superficial gastritis (CSG) patients were significant differences (P = 0.001). The average optical density (AOD) values of COX-2 staining in CSG, CAG, IM and DYS patients were 13.81 +/- 5.53, 45.28 +/- 21.44, 73.67 +/- 26.02 and 91.23 +/- 45.11, respectively, with significant differences among CSG, CAG and IM patients (P = 0.037, 0.001 and 0.047 for CSG vs CAG, CSG vs IM and CAG vs IM, respectively). The expression level of VEGF in DYS patients was significantly higher than those in other patients (P = 0.001, 0.001 and 0.001 for DYS vs CSG, DYS vs CAG and DYS vs IM, respectively). The expression levels of COX-2 in H. pylori-positive IM, CAG and DYS patients were significantly higher than those in H. pylori-negative counterparts (P = 0.043, 0.009, 0.001, respectively). Additionally, the expression level of COX-2 was positively correlated with that of VEGF with the aggravation of gastric mucosal lesions (r = 0.640, P = 0.006).
Conclusion: H. pylori infection might be able to induce the expression of COX-2 in precancerous gastric lesions, which in turn upregulates the expression of VEGF.
Similar articles
-
[Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof].Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2683-9. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17199977 Chinese.
-
Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.J Exp Clin Cancer Res. 2003 Sep;22(3):371-8. J Exp Clin Cancer Res. 2003. PMID: 14582693
-
Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.Clin Cancer Res. 2003 Nov 1;9(14):5245-51. Clin Cancer Res. 2003. PMID: 14614005
-
Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.World J Gastroenterol. 2016 Jan 21;22(3):1311-20. doi: 10.3748/wjg.v22.i3.1311. World J Gastroenterol. 2016. PMID: 26811668 Free PMC article. Review.
-
[High-grade gastric intra-epithelial neoplasia (or dysplasia) treated by endoscopic mucosal resection].Ann Pathol. 2011 Oct;31(5):375-80. doi: 10.1016/j.annpat.2011.07.006. Epub 2011 Sep 28. Ann Pathol. 2011. PMID: 21982245 Review. French. No abstract available.
Cited by
-
Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility.World J Gastroenterol. 2021 Jul 28;27(28):4653-4666. doi: 10.3748/wjg.v27.i28.4653. World J Gastroenterol. 2021. PMID: 34366627 Free PMC article. Review.
-
VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers.Clin Transl Oncol. 2013 Apr;15(4):313-20. doi: 10.1007/s12094-012-0923-y. Epub 2012 Aug 8. Clin Transl Oncol. 2013. PMID: 22872519
-
Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood.R Soc Open Sci. 2018 Jun 13;5(6):171806. doi: 10.1098/rsos.171806. eCollection 2018 Jun. R Soc Open Sci. 2018. PMID: 30110485 Free PMC article.
-
Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer.Oncol Lett. 2017 Jul;14(1):579-586. doi: 10.3892/ol.2017.6240. Epub 2017 May 24. Oncol Lett. 2017. PMID: 28693208 Free PMC article.
-
In vitro anti-bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection.Chin Med. 2021 Apr 17;16(1):33. doi: 10.1186/s13020-021-00442-1. Chin Med. 2021. PMID: 33865425 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials